MyFinsight
Home
Blog
About
Net loss
-$92,900K
(63.63%↑ Y/Y)
Loss before income
taxes
-$81,200K
(64.63%↑ Y/Y)
Provision for income taxes
$11,700K
(-54.65%↓ Y/Y)
Labs
$382,900K
(3.57%↑ Y/Y)
Immunohematology
$134,200K
(1.44%↑ Y/Y)
Point Of Care
$108,200K
(16.34%↑ Y/Y)
Donor Screening
$4,000K
(-69.92%↓ Y/Y)
Molecular Diagnostics
$1,600K
(-71.43%↓ Y/Y)
Interest expense, net
$54,700K
(35.06%↑ Y/Y)
Operating loss
-$21,800K
(87.94%↑ Y/Y)
Other expense, net
-$4,700K
(44.05%↑ Y/Y)
Total revenues
$630,900K
(2.77%↑ Y/Y)
Cost of sales,
excluding amortization of...
$358,000K
(5.60%↑ Y/Y)
Selling, marketing and
administrative
$189,700K
(6.57%↑ Y/Y)
Amortization of intangible
assets
$49,000K
(2.30%↑ Y/Y)
Research and development
$48,700K
(6.56%↑ Y/Y)
Restructuring, integration and
other charges
$6,500K
(-96.37%↓ Y/Y)
Other operating
expenses
$800K
(-84.31%↓ Y/Y)
Back
Back
Income Statement
QuidelOrtho Corp (QDEL)
QuidelOrtho Corp (QDEL)
source: myfinsight.com